Breaking News, Collaborations & Alliances

Multiply Labs Automates Thermo Fisher’s Cell Therapy Instruments

The collaboration helps reduce costs and accelerates timelines, bringing cell therapy scalability and accessibility within reach.

Author Image

By: Charlie Sternberg

Associate Editor

Thermo Fisher Scientific’s advanced cell therapy instruments, including the Thermo Scientific Heracell VIOS Automated Access CO2 Incubator and the Gibco Cell Therapy Systems (CTS) Rotea Counterflow Centrifugation System, have been integrated with Multiply Labs’ robotic technology, enabling them to be fully automated for cell therapy manufacturing.   The goal of this collaboration is to support reduced costs, accelerate production timelines and improve scalability, helping innovative cell thera...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters